U.S. Physical Therapy (USPH)
(Delayed Data from NYSE)
$81.64 USD
-8.36 (-9.29%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $81.47 -0.17 (-0.21%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Balance Sheet
Fiscal Year End for US Physical Therapy, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 153 | 32 | 29 | 33 | 24 |
Receivables | 70 | 69 | 62 | 51 | 56 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 11 | 11 | 4 | 4 | 6 |
Total Current Assets | 233 | 111 | 95 | 88 | 85 |
Net Property & Equipment | 26 | 25 | 23 | 22 | 22 |
Investments & Advances | 12 | 12 | 12 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 619 | 603 | 521 | 402 | 370 |
Deposits & Other Assets | 3 | 4 | 2 | 2 | 2 |
Total Assets | 997 | 858 | 749 | 594 | 561 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 8 | 8 | 1 | 5 | 1 |
Accounts Payable | 4 | 7 | 6 | 1 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 55 | 37 | 46 | 60 | 31 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 102 | 85 | 83 | 93 | 61 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 25 | 21 | 14 | 8 | 10 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 139 | 176 | 118 | 17 | 50 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2 | 13 | 7 | 5 | 0 |
Minority Interest (Liabilities) | 175 | 168 | 155 | 132 | 138 |
Total Liabilities | 520 | 541 | 452 | 317 | 319 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 281 | 110 | 103 | 96 | 87 |
Retained Earnings | 224 | 233 | 224 | 212 | 184 |
Other Equity | 4 | 5 | 2 | 1 | 1 |
Treasury Stock | 32 | 32 | 32 | 32 | 32 |
Total Shareholder's Equity | 477 | 317 | 297 | 278 | 242 |
Total Liabilities & Shareholder's Equity | 997 | 858 | 749 | 594 | 561 |
Total Common Equity | 477 | 317 | 297 | 278 | 242 |
Shares Outstanding | 14.90 | 13.00 | 12.90 | 12.80 | 12.70 |
Book Value Per Share | 32.04 | 24.39 | 23.04 | 21.69 | 19.03 |
Fiscal Year End for US Physical Therapy, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 132 | 153 | 148 | 161 |
Receivables | NA | 77 | 70 | 71 | 71 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 12 | 11 | 9 | 10 |
Total Current Assets | NA | 221 | 233 | 229 | 242 |
Net Property & Equipment | NA | 26 | 26 | 26 | 25 |
Investments & Advances | NA | 12 | 12 | 12 | 12 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 651 | 619 | 635 | 614 |
Deposits & Other Assets | NA | 4 | 3 | 6 | 5 |
Total Assets | NA | 1,017 | 997 | 1,010 | 1,000 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 9 | 8 | 8 | 8 |
Accounts Payable | NA | 5 | 4 | 5 | 4 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 54 | 55 | 36 | 43 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 103 | 102 | 82 | 86 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 27 | 25 | 26 | 23 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 137 | 139 | 142 | 143 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 2 | 15 | 13 | |
Minority Interest (Liabilities) | NA | 191 | 175 | 175 | 166 |
Total Liabilities | NA | 536 | 520 | 517 | 510 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 284 | 281 | 279 | 277 |
Retained Earnings | NA | 224 | 224 | 239 | 238 |
Other Equity | NA | 6 | 4 | 7 | 6 |
Treasury Stock | NA | 32 | 32 | 32 | 32 |
Total Shareholder's Equity | NA | 481 | 477 | 494 | 490 |
Total Liabilities & Shareholder's Equity | NA | 1,017 | 997 | 1,010 | 1,000 |
Total Common Equity | 0 | 481 | 477 | 494 | 490 |
Shares Outstanding | 15.00 | 15.00 | 14.90 | 14.90 | 13.00 |
Book Value Per Share | 0.00 | 32.08 | 32.04 | 33.12 | 37.69 |